FDA Warns Against Ovarian Cancer Screening Tests

Patient Safety

On September 7, 2016, the Food and Drug Administration (FDA) warned women and their doctors that current tests being marketed as ovarian cancer screening tests are unreliable and could lead to false diagnoses. Summary of the Problem: The FDA described the problem in their recent safety communication as follows: Despite extensive research and published studies,…

Read More